CDT
CDT Equity Inc.Company Information
- Company Name
- CDT Equity Inc.
- CIK
- CIK0001896212
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- CDT: Nasdaq, CDTTW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CDT
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-08-28
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 2,068,290
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 142,268
- Shares outstanding
- 532,999
- Ownership
- 26.69%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -78.71%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Marketable Securities | - | - | - | - | - | - | - | 0 | 0 | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 3 | 3 | 4 | 7 | 6 | 6 | 3 | 1 | 2 | 3 | 6 | 10 | ||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 0 | 2 | 4 | 3 | 2 | 1 | 0 | 0 | 2 | 4 | 9 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Equity Method Investments | 123 | 123 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Prepaid Expense And Other Assets Noncurrent | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Assets | 127 | 127 | 6 | 9 | 8 | 8 | 4 | 3 | 3 | 5 | 7 | 12 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Deferred Compensation Liability Classified Noncurrent | - | - | - | - | - | - | - | - | 6 | - | 6 | - | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Accounts Payable Current | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | ||||||
| Accrued Professional Fees Current | - | - | - | - | - | - | - | - | - | - | 0 | 2 | ||||||
| Other Accrued Liabilities Current | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 23 | 22 | 13 | 4 | 4 | 5 | 11 | 12 | 9 | 8 | 2 | 5 | ||||||
| Employee Related Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Bank Overdrafts | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Loans Payable Current | - | - | - | - | - | - | - | 1 | 0 | - | - | - | ||||||
| Deferred Compensation Liability Current | - | - | - | - | - | - | - | 6 | - | - | - | - | ||||||
| Convertible Notes Payable | - | - | - | - | - | - | 1 | 1 | 1 | - | 1 | - | ||||||
| Deferred Revenue Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 3 | ||||||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Derivative Liabilities Noncurrent | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities | 24 | 22 | 13 | 4 | 4 | 5 | 11 | 12 | 9 | 8 | 8 | 13 | ||||||
| Common Stock Value | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 180 | 178 | 61 | 51 | 43 | 37 | 22 | 17 | 14 | 11 | 10 | 10 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 103 | 105 | -7 | 4 | 4 | 3 | -7 | -9 | -5 | -3 | -0 | -1 | ||||||
| Treasury Stock Common Value | - | - | - | - | -0 | - | - | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -77 | -72 | -68 | -47 | -40 | -34 | -29 | -27 | -20 | -15 | -11 | -12 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Liabilities And Stockholders Equity | 127 | 127 | 6 | 9 | 8 | 8 | 4 | 3 | 3 | 5 | 7 | 12 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 18.00 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | - | 250 | 250 | ||||||
| Common Stock Shares Issued | 1 | 5 | 0 | 1 | 2 | 10 | 0 | 1 | 1 | - | 1 | - | ||||||
| Shares Outstanding | 1 | 5 | 0 | 1 | 2 | 10 | 0 | 1 | 1 | - | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | 0 | 0 | - | - | - | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | 0 | 0 | - | - | - | ||||||
| Treasury Stock Common Shares | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCDT Equity Inc. (CDT) — SEC Financial Statements & Analysis
CDT Equity Inc. (CDT) is a pharmaceutical preparations company, incorporated in DE. CDT Equity Inc. trades on Nasdaq as: CDT, CDTTW. CDT Equity Inc. (CDT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, CDT Equity Inc. carries a market cap of $2.98M, a P/E ratio of -0.08x, a P/B ratio of 0.03x, an enterprise value of $2.24M, and an EV/EBITDA multiple of -0.06x. On profitability, it posts a Return on Equity (ROE) of -69.68%, a Return on Assets (ROA) of -55.16%, and a Return on Invested Capital (ROIC) of -67.97%. Per share, it reports EPS of $-69.69, diluted EPS of $-69.69, free cash flow per share of $-22.29, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 89.06% year-over-year and EPS growth of 95.45% year-over-year. On the balance sheet, it maintains a current ratio of 0.13x, a quick ratio of 0.08x, working capital of $-20.41M, a debt-to-equity ratio of 0.23x, a debt ratio of 0.19, an interest coverage ratio of -229.26x, free cash flow of $-11.88M (TTM), and net debt of $-747.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $2.98M
- P/E TTM
- -0.08x
- EPS TTM
- $-69.69
- P/B TTM
- 0.03x
- ROE TTM
- -69.68%
- ROA TTM
- -55.16%
- Debt To Equity
- 0.23x
- Free Cash Flow TTM
- $-11.88M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CDT Equity Inc. in?
CDT Equity Inc. (CDT) operates in the Pharmaceutical Preparations industry.
What exchange does CDT trade on?
CDT Equity Inc. (CDT) trades on the Nasdaq.
Where is CDT Equity Inc. incorporated?
CDT Equity Inc. is incorporated in DE.
When was CDT Equity Inc. (CDT)'s most recent SEC filing?
CDT Equity Inc. (CDT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is CDT's market cap?
CDT Equity Inc. (CDT) has a market capitalization of $2.98M as of 2026-06-30.
What is CDT's EPS (earnings per share)?
CDT Equity Inc. (CDT)'s trailing twelve month EPS is $-69.69 as of 2026-06-30.
What is CDT's ROE (return on equity)?
CDT Equity Inc. (CDT)'s trailing twelve month Return on Equity (ROE) is -69.68% as of 2026-06-30.
What is CDT's ROA (return on assets)?
CDT Equity Inc. (CDT)'s trailing twelve month Return on Assets (ROA) is -55.16% as of 2026-06-30.
What is CDT's ROIC (return on invested capital)?
CDT Equity Inc. (CDT)'s trailing twelve month Return on Invested Capital (ROIC) is -67.97% as of 2026-06-30.
What is CDT's EV/EBITDA?
CDT Equity Inc. (CDT)'s trailing twelve month EV/EBITDA is -0.06x as of 2026-06-30.